阿尔帕索电力 EE 深 沪
等待开盘 01-12 09:30:00 美东时间
30.45
+0.690
+2.32%
华盛通- 最 高30.94
- 今 开30.00
- 成交量 31.25万股
- 最 低 29.98
- 昨 收 29.76
- 总市值 9.75亿
- 52周最高 32.71
- 市盈率 静 23.94
- 换手率 0.98%
- 52周最低 21.125
- 委 比 -50.00%
- 总股本 3200.96万
- 历史最高 32.71
- 量 比 1.18
- 振 幅 3.23%
- 历史最低 12.965
- 每 手 1
- 风险率 2.20%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅36.7%！LMRI获多家大行首予超配评级； 瑞银下调甲骨文目标价从325美元至280美元
今日重点评级关注：HC Wainwright & Co.：维持Assertio Holdings"买入"评级，目标价从3美元升至35美元；HC Wainwright & Co.：维持万达生物制药"买入"评级，目标价从20美元升至22美元
01-06 17:52
Raymond James Upgrades Excelerate Energy to Strong Buy, Maintains Price Target to $36
Raymond James analyst Justin Jenkins upgrades Excelerate Energy (NYSE:EE) from Outperform to Strong Buy and maintains the price target from $36 to $36.
01-06 01:39
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 10:22
Morgan Stanley Upgrades Excelerate Energy to Equal-Weight, Raises Price Target to $30
Morgan Stanley analyst Devin McDermott upgrades Excelerate Energy (NYSE:EE) from Underweight to Equal-Weight and raises the price target from $28 to $30.
2025-11-07 17:30
Earnings Scheduled For November 5, 2025
Companies Reporting Before The Bell • Avient (NYSE:AVNT) is estimated to report...
2025-11-05 19:12
Entergy reports third quarter 2025 financial results
Company narrows guidance range and extends financial outlooks NEW ORLEANS, Oct. 29, 2025 /PRNewswire/ -- Entergy Corporation (NYSE: ETR) reported third quarter 2025 earnings per share of $1....
2025-10-29 18:30
GRP Limited Updates on Legal Dispute with EESB
An update from GRP Ltd. ( ($SG:BLU) ) is now available. GRP Limited has announc...
2025-10-29 18:12
